USFDA

Zydus Cadila gets tentative USFDA nod to market lung cancer treatment drug

Zydus Cadila gets tentative USFDA nod to market lung cancer treatment drug

June 3, 2021

Lupin announces USFDA acceptance for a biosimilar application

Lupin announces USFDA acceptance for a biosimilar application

June 2, 2021

Natco Pharma gets American drug regulator's nod for generic cancer treatment drug

Natco Pharma gets American drug regulator’s nod for generic cancer treatment drug

May 22, 2021

Morepen Labs: Morepen gets shareholder nod to raise Rs 433 crore

Morepen Labs: Morepen gets shareholder nod to raise Rs 433 crore

May 21, 2021

mutual funds: Go for a multicap strategy to beat Covid blues: Jinesh Gopani

mutual funds: Go for a multicap strategy to beat Covid blues: Jinesh Gopani

May 18, 2021

NATCO: Covid drug: Natco eyes patent waiver

NATCO: Covid drug: Natco eyes patent waiver

May 6, 2021

rakesh jhunjhunwala: Expect Nifty to give high teen returns for next 8-10 years: Rakesh Jhunjhunwala

rakesh jhunjhunwala: Expect Nifty to give high teen returns for next 8-10 years: Rakesh Jhunjhunwala

February 24, 2021

Cadila Healthcare Q3 results: Net profit up 41% to Rs 527 crore

Cadila Healthcare Q3 results: Net profit up 41% to Rs 527 crore

February 5, 2021

new bull market: Ravi Dharamshi on what is in store for markets in 2021

new bull market: Ravi Dharamshi on what is in store for markets in 2021

January 1, 2021

Biocon Share Price: Biocon tanks 4% as USFDA defers decision on Avastin biosimilar application

Biocon Share Price: Biocon tanks 4% as USFDA defers decision on Avastin biosimilar application

December 28, 2020